AALBERTS NV (AALB.AS)

NL0000852564 - Common Stock

40.39  +0.63 (+1.58%)


Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to AALB. AALB was compared to 43 industry peers in the Machinery industry. While AALB has a great profitability rating, there are some minor concerns on its financial health. AALB has a valuation in line with the averages, but on the other hand it scores bad on growth




Profitability

Profitability Rating

7

AALB's Return On Assets of 7.54% is amongst the best returns of the industry. AALB outperforms 86% of its industry peers. The industry average Return On Assets is 4.81%.
AALB has a Return On Equity of 13.69%. This is better than the industry average of 12.69%.

AALB has a Profit Margin of 9.82%. This is amongst the best returns in the industry. The industry average is 4.81%. AALB outperforms 92% of its industry peers.
AALB has a Piotroski-F score of 4.00. This indicates an average health and profitability for AALB.
VS Industry

ROA (7.54%) VS Industry: 86% outperformed.

0.32
23.26

ROE (13.69%) VS Industry: 65% outperformed.

0.52
34.57

Profit Margin (9.82%) VS Industry: 92% outperformed.

0.37
22.96

Valuation

Valuation Rating

5

The Price/Earnings Ratio is 10.46, which indicates a very decent valuation of AALB.
Compared to an average industry Price/Earning Ratio of 15.77, AALB is valued a bit cheaper than its industry peers.
The Forward Price/Earnings Ratio of 12.39 indicates a correct valuation of AALB.
The PEG Ratio, which compensates the Price/Earnings for growth, indicates a correct valuation of the company.

With a price book ratio of 1.93, AALB is valued correctly.
Compared to an average industry price book ratio of 1.73, AALB is valued in line with its industry peers.
When comparing the Enterprise Value to EBITDA ratio of AALB to the average industry ratio of 9.40, AALB is valued in line with its industry peers.
VS Industry

Price/Earnings (10.46) VS Industry: 73% outperformed.

208.00
6.14

Price/Book (1.93) VS Industry: 41% outperformed.

8.32
0.64

Enterprise Value/ EBITDA (7.94) VS Industry: 55% outperformed.

38.69
1.88

Growth

Growth Rating

3

Measured over the past 5 years, AALB shows a small growth in Earnings Per Share. The EPS has been growing by 9.20% on average per year.
Based on estimates for the next 5 years, AALB will show a small growth in Earnings Per Share. The EPS will grow by 1.22% on average per year.
AALB shows a small growth in Revenue. In the last year, the Revenue has grown by 8.42%.
Measured over the past 5 years, AALB shows a small growth in Revenue. The Revenue has been growing by 3.70% on average per year.

Based on estimates for the next 5 years, AALB will show a small growth in Revenue. The Revenue will grow by 4.39% on average per year.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is stable.
The earnings per share for AALB have decreased strongly by -11.70% in the last year.
When comparing the EPS growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is decreasing.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS9.2% 12.09% -11.7% -15.53% -3.74% -0.41% 1.22%
Revenue3.7% 4.37% 8.42% 2.66% 3.55% 3.81% 4.39%

Health

Health Rating

5

AALB has an Altman-Z score of 3.35. This indicates that AALB is financially healthy and little risk of bankruptcy at the moment.
When comparing the Altman-Z score to an average industry score of 2.10, AALB is in better financial health than the average industry peer.
A Current Ratio of 1.48 indicates that AALB should not have too much problems paying its short term obligations.
The Current Ratio is in line with the industry averages, which is at 1.48.

The Debt to Equity ratio of AALB is in line with the industry averages.
The Piotroski-F score of AALB is 4.00. This is a neutral score and indicates average health and profitability for AALB.
AALB has a Quick Ratio of 1.48. This is a bad value and indicates that AALB is not financially healthy enough and could expect problems in meeting its short term obligations.
When comparing the Quick Ratio of AALB to the average industry Current Ratio of 0.91, AALB is less able to pay its short term obligations than its industry peers. 85% of its industry peers have a better Quick Ratio.
VS Industry

Debt/Equity (0.27) VS Industry: 58% outperformed.

2.20
0.00

Quick Ratio (0.57) VS Industry: 15% outperformed.

0.48
31.70

Current Ratio (1.48) VS Industry: 50% outperformed.

0.50
32.76

Altman-Z (3.35) VS Industry: 77% outperformed.

-6.64
62.37

Dividend

Dividend Rating

5

AALB's Dividend Yield is a higher than the industry average which is at 2.45.
The dividend of AALB is nicely growing with an annual growth rate of 23.28%!
AALB has a Yearly Dividend Yield of 2.72%. Purely for dividend investing, there may be better candidates out there.

Compared to an average S&P500 Dividend Yield of 2.71, AALB has a dividend comparable with the average S&P500 company.
AALB pays out 57.52% of its income as dividend. This is a bit on the high side, but may be sustainable.
AALB's earnings are declining while the Dividend Rate has been growing. This means the dividend growth is most likely not sustainable.
VS Industry

Dividend Yield (2.72%) VS Industry: 65% outperformed.

0.53
4.68

AALBERTS NV

AMS:AALB (6/2/2023, 5:29:37 PM)

40.39

+0.63 (+1.58%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap4.47B
Analysts83.08
Price Target55.4 (37.16%)
Dividend
Industry RankSector Rank
Dividend Yield 2.72%
Dividend Growth(5Y)23.28%
DP57.52%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)68.29%
Min EPS beat(2)68.29%
Max EPS beat(2)68.29%
EPS beat(4)2
Avg EPS beat(4)40.94%
Min EPS beat(4)13.59%
Max EPS beat(4)68.29%
Revenue beat(2)N/A
Avg Revenue beat(2)-1.08%
Min Revenue beat(2)-1.08%
Max Revenue beat(2)-1.08%
Revenue beat(4)N/A
Avg Revenue beat(4)-1.04%
Min Revenue beat(4)-1.08%
Max Revenue beat(4)-1%
PT rev (1m)-0.6%
PT rev (3m)2.75%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)18.13%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)4.65%
Valuation
Industry RankSector Rank
PE 10.46
Fwd PE 12.39
P/S 1.38
P/FCF 98.59
P/OCF 18.06
P/B 1.93
P/tB 5.81
EV/EBITDA 7.94
EPS(TTM)3.86
EY9.56%
EPS(NY)3.26
Fwd EY8.07%
FCF(TTM)0.41
FCFY1.01%
OCF(TTM)2.24
OCFY5.54%
SpS29.21
BVpS20.97
TBVpS6.96
PEG (NY)N/A
PEG (5Y)1.14
Profitability
Industry RankSector Rank
ROA 7.54%
ROE 13.69%
ROIC 9.93%
ROICexc 10.17%
ROICexgc 19.18%
OM 13.79%
PM 9.82%
GM 62.41%
ROA(3y)7%
ROA(5y)7.01%
ROE(3y)12.37%
ROE(5y)12.8%
ROIC(3y)9.73%
ROIC(5y)9.7%
ROICexc(3y)9.97%
ROICexc(5y)9.93%
ROICexgc(3y)19.78%
ROICexgc(5y)19.99%
ROICexcg growth 3Y1.46%
ROICexcg growth 5Y-2.48%
ROICexc growth 3Y3.48%
ROICexc growth 5Y-0.59%
OM growth 3Y6.81%
OM growth 5Y4.21%
PM growth 3Y7.34%
PM growth 5Y5.29%
GM growth 3Y-0.42%
GM growth 5Y0.11%
F-Score4
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF 19.27
Debt/EBITDA 1.38
Cap/Depr 107.39%
Profit Quality 14.28%
Current Ratio 1.48
Quick Ratio 0.57
Altman-Z 3.35
F-Score4
WACC6.91%
ROIC/WACC2.78
Cap/Depr(3y)82.43%
Cap/Depr(5y)88.27%
Profit Quality(3y)91.02%
Profit Quality(5y)89.71%
Growth
EPS 1Y-11.7%
EPS 3Y12.09%
EPS 5Y9.2%
EPS growth Q2Q43.42%
EPS Next Y-15.53%
EPS Next 2Y-3.74%
EPS Next 3Y-0.41%
EPS Next 5Y1.22%
Revenue growth 1Y8.42%
Revenue growth 3Y4.37%
Revenue growth 5Y3.7%
Revenue growth Q2Q10.01%
Revenue Next Year2.66%
Revenue Next 2Y3.55%
Revenue Next 3Y3.81%
Revenue Next 5Y4.39%
EBIT growth 1Y-11.99%
EBIT growth 3Y11.48%
EBIT growth 5Y8.06%
EBIT Next Year45.24%
EBIT Next 3Y17.72%
EBIT Next 5YN/A
FCF growth 1Y-66.42%
FCF growth 3Y-40.96%
FCF growth 5Y-26.82%
OCF growth 1Y-15.22%
OCF growth 3Y-13.17%
OCF growth 5Y-5.96%
Fundamental Stock Screener Links
Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the EuroNext

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the EuroNext

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the EuroNext

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the EuroNext